Evidence map›Paper›PMID 35956191›Full record

ArticleJournal of clinical medicine2022

Test Performance Characteristics of Dynamic Liver Enzyme Trends in the Prediction of Choledocholithiasis.

Yang Lei, B Cord Lethebe, Erin Wishart, Fateh Bazerbachi, B Joseph Elmunzer, Nirav Thosani, James L Buxbaum, Yen-I Chen, Sydney Bass, Martin J Cole and 5 more

Open access · goldAbstract read
In one paragraph

Article in Journal of clinical medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 7 institutions in 2 countries.

Yang LeiDepartment of Medicine, Cumming School of Medicine, University of Calgary, Calgary, AB T2N 4N1, Canada.ORCID 0000-0003-4105-6353
B Cord LethebeClinical Research Unit, Cumming School of Medicine, University of Calgary, Calgary, AB T2N 4N1, Canada.
Erin WishartDepartment of Medicine, Cumming School of Medicine, University of Calgary, Calgary, AB T2N 4N1, Canada.
Fateh BazerbachiCentraCare, Interventional Endoscopy Program, St. Cloud Hospital, St. Cloud, MN 56303, USA.ORCID 0000-0003-4599-2042
B Joseph ElmunzerDivision of Gastroenterology and Hepatology, Medical University of South Carolina, Charleston, SC 29425, USA.
Nirav ThosaniCenter for Interventional Gastroenterology (iGUT), McGovern Medical School, UTHealth, Houston, TX 77030, USA.
James L BuxbaumDivision of Gastrointestinal and Liver Diseases, Keck School of Medicine, University of Southern California, Los Angeles, CA 90033, USA.
Yen-I ChenDepartment of Medicine, McGill University, Montreal, QC H3A 1A1, Canada.
Sydney BassDepartment of Medicine, Cumming School of Medicine, University of Calgary, Calgary, AB T2N 4N1, Canada.
Martin J ColeDepartment of Medicine, Cumming School of Medicine, University of Calgary, Calgary, AB T2N 4N1, Canada.
Christian TurbideDepartment of Medicine, Cumming School of Medicine, University of Calgary, Calgary, AB T2N 4N1, Canada.
Darren R BrennerDepartment of Community Health Sciences, Cumming School of Medicine, University of Calgary, Calgary, AB T2N 1N4, Canada.
Steven J HeitmanDepartment of Medicine, Cumming School of Medicine, University of Calgary, Calgary, AB T2N 4N1, Canada.
Rachid MohamedDepartment of Medicine, Cumming School of Medicine, University of Calgary, Calgary, AB T2N 4N1, Canada.
Nauzer ForbesDepartment of Medicine, Cumming School of Medicine, University of Calgary, Calgary, AB T2N 4N1, Canada.
University of Calgary · CAAlberta Health Services · CAMcGill University · CAMedical University of South Carolina · USSt. Cloud Hospital · USThe University of Texas Health Science Center at Houston · USUniversity of Southern California · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

(1) Background: Various methods to predict the presence or absence of choledocholithiasis (CDL) have been proposed. We aimed to assess the performance characteristics of dynamic liver enzyme trends in the prediction of CDL. (2) Methods: This was a single-center retrospective cohort study. All adult in-patients undergoing endoscopy for suspected CDL between 1 January 2012 and 7 October 2018 were identified, with patients with prior cholecystectomy, prior sphincterotomy, or indwelling biliary prostheses were excluded. Available laboratory parameters within 72 h preceding the procedure were recorded, allowing for the assessment of trends. Dynamic enzyme trends were defined as any increase or decrease by 30% and 50% within 72 h of the index procedure. (3) Results: A total of 878 patients were included. Mean age was 61.8 years, with 58.6% female. Increases in alkaline phosphatase (ALP) of at least 30% or 50% were both specific for the presence of CDL, with specificities of 82.7% (95% CI 69.7-91.8%) and 88.5% (95% CI 76.6-95.6%), respectively. Decreases in bilirubin or ALP of at least 50% were highly specific for the absence of CDL, with specificities of 91.7% (95% CI 85.7-95.8%) and 100.0% (97.2-100.0%), respectively. (4) Conclusions: Several liver enzyme trends appear to be specific for the absence or presence of stones; in particular, significant decreases in total bilirubin or ALP of at least 30-50% over the prior 72 h appear to be especially predictive of an absence of intraductal findings during endoscopy.

Indexed as

choledocholithiasisERCPEUS

Identifiers

PMID35956191
PMCPMC9369577
OpenAlexW4290517659

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.